诉讼背景 - Rosen Law Firm提醒在2023年3月24日至2025年5月14日期间购买Biohaven Ltd (NYSE: BHVN) 证券的投资者 需在2025年9月12日前申请成为首席原告 [1] - 投资者可能通过风险代理收费安排获得补偿 无需支付自付费用 [1] 诉讼参与方式 - 参与集体诉讼需通过指定链接提交表单或联系Phillip Kim律师 (电话866-767-3653/邮箱case@rosenlegal.com) [2][5] - 首席原告需在2025年9月12日前向法院提出申请 代表其他集体成员指导诉讼 [2] - 在集体认证前投资者可自行选择律师或保持缺席成员身份 未来赔偿分配不取决于是否担任首席原告 [6] 律所资质说明 - Rosen Law Firm专注于证券集体诉讼和股东派生诉讼 2017年因和解案件数量被ISS Securities Class Action Services评为第一 [3] - 2013年起每年位列行业前四 累计为投资者追回数亿美元 2019年单年获赔4.38亿美元 [3] - 创始合伙人Laurence Rosen于2020年被law360评为原告律师界泰斗 多名律师获Lawdragon和Super Lawyers认可 [3] 案件指控内容 - 指控被告在集体诉讼期间作出虚假陈述 未披露Troriluzole药物治疗脊髓小脑共济失调(SCA)的监管前景及支持数据存在过度夸大 [4] - BHV-7000药物治疗双相情感障碍的疗效和临床前景同样被过度夸大 [4] - 真相披露后对公司业务和财务状况造成重大负面影响 导致投资者遭受损失 [4]

WHAT'S NEXT? If you suffered a loss in Biohaven Ltd. during the relevant time frame, you have until September 12, 2025Â to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. Accessibility StatementSkip Navigation NEW YORK, Sept. 12, 2025 /PR ...

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Biohaven Ltd. investors who were adversely affected by alleged securities fraud between March 24, 2023 and May 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-su ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Biohaven Ltd. ("Biohaven†or the "Company†) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO LOST MONEY ON BIOHAVEN LTD. (BHVN), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAU. ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Biohaven (BHVN) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockhold ...

诉讼背景 - 罗森律师事务所提醒在2023年3月24日至2025年5月14日期间购买Biohaven Ltd（NYSE: BHVN）证券的投资者 关于2025年9月12日的重要首席原告截止日期 [1] - 投资者可能有权通过风险代理收费安排获得补偿 无需支付任何自付费用或成本 [1] 诉讼参与方式 - 参与集体诉讼需通过指定链接提交表格 或联系Phillip Kim律师（电话866-767-3653 邮箱case@rosenlegal.com）[2][5] - 首席原告需在2025年9月12日前向法院提出动议 代表其他集体成员指导诉讼 [2] - 在集体认证前 投资者可自行选择律师或保持缺席成员身份 分享潜在赔偿与是否担任首席原告无关 [6] 律师事务所资质 - 罗森律师事务所在证券集体诉讼领域具有显著成就 2017年因和解案件数量被ISS证券集体诉讼服务评为第一名 [3] - 该律所自2013年起每年排名前四 累计为投资者追回数亿美元 其中2019年单年获得4.38亿美元赔偿 [3] - 创始合伙人Laurence Rosen于2020年被law360评为原告律师界领军人物 多名律师获得Lawdragon和Super Lawyers认可 [3] 案件指控细节 - 指控被告在诉讼期间作出虚假和误导性陈述 未披露Troriluzole药物治疗脊髓小脑共济失调（SCA）的监管前景和数据充分性被夸大 [4] - BHV-7000药物治疗双相情感障碍的疗效和临床前景同样被夸大 这些事实披露后对公司业务和财务状况产生重大负面影响 [4] - 指控被告的公开陈述在所有相关时间均存在重大虚假和误导性 导致投资者在市场知悉真相后遭受损失 [4]

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Biohaven (BHVN) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockhold ...

NEW YORK--(BUSINESS WIRE)---- $BHVN #BHVN--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Biohaven Ltd. ("Biohaven†or the "Company†) (NYSE: BHVN). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. On May 14, 2025, Biohaven issued a press release "announc[in. ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) The company's product candidate, troriluzole's regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole's regulat ...

集体诉讼案件背景 - 罗森律师事务所提醒在2023年3月24日至2025年5月14日期间购买Biohaven Ltd (NYSE: BHVN) 证券的投资者 关于2025年9月12日的重要首席原告截止日期 [1] 诉讼指控内容 - 指控被告在整个集体诉讼期间做出虚假和误导性陈述及/或未能披露：troriluzole作为脊髓小脑共济失调（SCA）治疗药物的监管前景和/或Biohaven为支持该适应症监管批准所提交数据的充分性被夸大 [5] - BHV-7000作为双相情感障碍治疗药物的功效和临床前景同样被夸大 [5] - 上述情况的披露可能对Biohaven的业务和财务状况产生重大负面影响 [5] - 被告的公开陈述在所有相关时间均存在重大虚假和误导性 [5] 律师事务所资质说明 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 在全球代表投资者 [4] - 该律所曾达成针对中国公司的史上最大证券集体诉讼和解 [4] - 2017年被ISS证券集体诉讼服务部门按和解案件数量排名第一 2013年以来每年均排名前四 [4] - 2019年单独为投资者追回超过4.38亿美元 [4] - 2020年创始合伙人Laurence Rosen被law360评为原告律师界泰斗 [4]